Advertisement · 728 × 90

Posts by Journal of Health Economics and Outcomes Research

Post image

New in JHEOR: A US retrospective study found that PIVC-related complications occur in roughly 0.5%-1% of surgical patients, driving significantly higher readmission risks, extended hospital stays, and tens of thousands of dollars in excess costs for both adults and children. jheor.org/article/156489

1 week ago 0 0 0 0
Preview
Trump’s Personnel Agency Is Asking for Federal Workers’ Medical Records - KFF Health News The administration is asking insurers that cover federal employees and retirees to hand over details about their medical visits, their pharmacy claims, and more.

kffhealthnews.org/news/article...

1 week ago 0 0 0 0
All-cause healthcare spending in patients with multifocal motor neuropathy.

All-cause healthcare spending in patients with multifocal motor neuropathy.

New real-world study, using Medicare Advantage claims data, highlights the considerable burden associated with multifocal motor neuropathy on patients and the healthcare system. jheor.org/article/1581... #neuropathy #RealWorldData

2 weeks ago 0 0 0 0
Bullet-point summary of study

Bullet-point summary of study

US-based analysis finds that shortening ART restart delays from 32 to 12 weeks results in 88 transmissions averted and lifetime healthcare savings of $101 million by improving viral suppression and CD4 counts. #HEOR #HIV #ART #PublicHealth

3 weeks ago 1 0 0 0
Post image

While clean-fuel households in Nigeria spend more for cooking energy and respiratory health care than those using polluting fuels, a model-based analysis showed clean fuels to be cost-effective. #CleanFuel #Nigeria #HEOR

1 month ago 0 0 0 0
Post image

Retrospective commercial claims analysis of patients with congenital pulmonary valve disease through age 65 quantifies the lifelong burden. High early hospitalization rates and average cumulative lifetime costs exceeding $2 million by age 65 underscore the need for improved early care. #HEOR

1 month ago 0 0 0 0
Post image

New in JHEOR: A Markov model, evaluating the Canadian fiscal impact of treating inadequately controlled generalized myasthenia gravis with efgartigimod vs current therapies, found reduced lifetime public burden and positive government return on investment. #MyastheniaGravis jheor.org/article/157709

1 month ago 0 0 0 0
Infographic with Common Health Coalition logo at the top. Text reads, "More Illness, Greater Cost Spotlight Brief: Childhood Immunizations. By 2030, a 1% decline per year in MMR vaccination coverage could result in ~$1.5 billion in annual added costs. $41.1 million in direct medical costs. $947.0 million in public health outbreak response costs. $510.4M in productivity and missed work costs. Website at the bottom of the graphic: www.CommonHealthCoalition.org

Infographic with Common Health Coalition logo at the top. Text reads, "More Illness, Greater Cost Spotlight Brief: Childhood Immunizations. By 2030, a 1% decline per year in MMR vaccination coverage could result in ~$1.5 billion in annual added costs. $41.1 million in direct medical costs. $947.0 million in public health outbreak response costs. $510.4M in productivity and missed work costs. Website at the bottom of the graphic: www.CommonHealthCoalition.org

New analysis from the Common Health Coalition and researchers at the @yalesph.bsky.social highlights the widespread consequences of declining childhood vaccination coverage. ow.ly/Ox2450YmJtG

1 month ago 23 14 1 1
This study examined the effect of head and neck cancer (HNC) treatment on household financial vulnerability and potential need for catastrophic income loss protection. HNC carries high morbidity, and treatment can cause serious functional impairment.

A cross-sectional simulation used responses from US adults aged 35–64 in the US Federal Reserve 2023 SHED survey.

With complete income loss, 16% of simulated patients were insolvent by 3 months, increasing sharply to nearly half by 6 months. Partial income loss substantially reduced insolvency risk, while access to liquid savings further protected households from short-term financial collapse during treatment.

Results highlight severe financial vulnerability during HNC care, supporting expanded income protection programs and broader evaluation of cancer-related household hardship.

This study examined the effect of head and neck cancer (HNC) treatment on household financial vulnerability and potential need for catastrophic income loss protection. HNC carries high morbidity, and treatment can cause serious functional impairment. A cross-sectional simulation used responses from US adults aged 35–64 in the US Federal Reserve 2023 SHED survey. With complete income loss, 16% of simulated patients were insolvent by 3 months, increasing sharply to nearly half by 6 months. Partial income loss substantially reduced insolvency risk, while access to liquid savings further protected households from short-term financial collapse during treatment. Results highlight severe financial vulnerability during HNC care, supporting expanded income protection programs and broader evaluation of cancer-related household hardship.

New in JHEOR: Head and neck cancer treatment causes rapid household insolvency risk, highlighting need for income protection programs, based on simulation using US survey data. jheor.org/article/155597 #HEOR #CancerTreatment #CatastrophicIllness

1 month ago 0 0 0 0
Preview
Robert F Kennedy Jr: 1 year of failure In his first speech as Secretary of the US Department of Health and Human Services (HHS), Robert F Kennedy Jr laid out a plan to restore trust. The COVID-19 pandemic saw public faith in Federal health...

Robert F Kennedy Jr: 1 year of failure - The Lancet www.thelancet.com/journals/lan...

1 month ago 0 0 0 0
Advertisement
Post image

Novel 1-pill regimen tamps down virus in older adults with HIV, study suggests

The regimen combining bictegravir and lenacapavir provided similar viral suppression as multi-pill antiretroviral therapy

www.cidrap.umn.edu/h...

1 month ago 20 5 1 1
Preview
Washington University plans to acquire St. Louis College of Pharmacy University of Health Sciences and Pharmacy officials said the decision is a way to keep the 162-year-old institution viable as higher education institutions face financial challenges

Washington University's acquisition of St. Louis College of Pharmacy, if approved by government regulators, would establish the WashU St. Louis College of Pharmacy as the university’s 10th academic school.

1 month ago 0 0 0 0
This study examined antiretroviral therapy switching patterns among treatment-experienced people with HIV to inform shared decision-making and optimize long-term
regimen selection.

This study examined antiretroviral therapy switching patterns among treatment-experienced people with HIV to inform shared decision-making and optimize long-term regimen selection.

New Optum claims analysis finds that treatment-experienced people with HIV receiving bictegravir/emtricitabine/tenofovir had greater regimen durability and lower switching risk than other antiretroviral therapies, including Medicare Advantage populations. jheor.org/article/156180 #HEOR #HIV #ART

1 month ago 2 0 0 0
Post image

New modeling study: QALY-based cost-effectiveness analyses undervalue life-extending Duchenne muscular dystrophy treatments, favoring delayed progression over mortality gains and highlighting limitations of traditional value frameworks. #HEOR #qalys #musculardystrophy jheor.org/article/156118

2 months ago 0 0 0 0
Post image

New in JHEOR: A lifetime Markov model showed that adjuvant trastuzumab-emtansine is cost-effective and cost-saving vs trastuzumab for HER2+ breast cancer with residual disease in Colombia. jheor.org/article/156056 #HEOR #breastcancer

2 months ago 0 0 0 0
Photo of Dr. jones

Photo of Dr. jones

Dr. Camara Phyllis Jones is an American physician, epidemiologist, and anti-racism activist who specializes in the effects of racism and social inequalities on health.

Dr. Jones’ work focuses on naming, measuring, & addressing the impacts of racism on health & wellbeing.

#BlackHistoryMonth

2 months ago 219 54 0 0
Preview
To lower overall health care spending, spend more on primary care, a new report argues Specialists are expensive.

To lower overall health care spending, spend more on primary care, a new report argues www.marketplace.org/story/2026/0...

2 months ago 0 0 0 0
Advertisement
Post image

Price competition within government procurement can exacerbate fraud by selecting on low-cost, fraudulent firms. New evidence from Medicare durable medical equipment, from Renuka Diwan, Paul Eliason, Riley League, Jetson Leder-Luis, Ryan McDevitt, and James Roberts www.nber.org/papers/w34802

2 months ago 3 1 0 0
Post image

Patient interviews within a phase 1/2 open-label trial show that DTX401 gene therapy reduces treatment burden and improves quality of life in adults with glycogen storage disease type Ia (GSDIa). jheor.org/article/155666 #HEOR #GSDIa #genetherapy

2 months ago 0 0 0 0
Post image

Amicus brief filed against RFK Jr attacks ‘shared clinical decision-making’

Groups are warning that recent federal actions weakening routine childhood vaccination recommendations pose an urgent threat both for children and the public’s health.

www.cidrap.umn.edu/c...

2 months ago 50 19 0 1
Preview
SES and Postpartum Depression Risk by State Trigger Laws After Dobbs This cohort study analyzes associations of state-level abortion bans enacted after the Dobbs v Jackson Women’s Health Organization decision with incidence of postpartum depression among individuals wi...

Post-Dobbs abortion bans disproportionately associated with increased PPD risk among individuals in low-SES communities, amplifying existing health disparities. #postpartum #depression #Dobbs #abortion

2 months ago 0 0 0 0
Post image

Large share of older US adults haven’t had a recent flu or COVID vaccine, poll finds

Of adults ages 50 and older, 42% remain unvaccinated.

www.cidrap.umn.edu/c...

2 months ago 27 19 0 4

I am hearing that RFK Jr.’s minions are going to go after HPV vaccines. I’ve got problems with these people and now you’re going to hear about them, first from a personal perspective and then from a professional one.

It all boils down to this: WE HAVE A SAFE VACCINE THAT PREVENTS CANCER.

2 months ago 5053 1771 126 135
Post image

Universal self-collection of cervical samples may hike #HPV screening rates

Offering self-collection to all women can improve health equity and speed the global elimination of cervical cancer, the authors say.

www.cidrap.umn.edu/h...

2 months ago 27 13 1 0
Post image

New study in JHEOR assesses the cost-effectiveness of the TYRX antibacterial envelope in preventing cardiac implantable electronic device infections in Spain, showing it is cost-effective or cost-saving across device types. #HEOR #InfectionControl #Spain #MedicalDevices jheor.org/article/154974

2 months ago 0 0 0 0
Post image

New study evaluating real-world Medicare data shows reduced healthcare utilization after pimavanserin initiation in newly diagnosed, treatment-naïve Parkinson’s disease psychosis patients. jheor.org/article/154805 #Parkinsons #pimavanserin #HEOR

2 months ago 0 0 0 0
Advertisement
Preview
Controversial US study on hepatitis B vaccines in Africa is cancelled $1.6m project drew outrage over ethical questions about withholding vaccines proven to prevent disease

Remember that exploitative and unethical clinical trial of HepB vaccine in Guinea-Bissau that RFK Jr. funded?

It’s been cancelled.

3 months ago 613 174 16 12
Preview
How Medical Costs for People with Dementia Are Changing Over Time and Across the U.S. - January 15, 2026 - USC Schaeffer Explore medical spending for Medicare beneficiaries with dementia in this interactive from the U.S. Cost of Dementia project. - January 15, 2026

📊 This new interactive from USC Schaeffer lets researchers and policymakers explore how medical spending for Medicare beneficiaries with #dementia has changed across time, states, demographics and care settings.

Explore the data here ⤵️

3 months ago 0 1 0 0
Preview
Q&A with economist W. Kip Viscusi As a major federal agency reportedly moves away from monetizing the health benefits of regulations, the economist who developed those metrics weighs in.

As the EPA reportedly plans to move away from putting dollar figures on the costs of premature deaths toward industry costs, the economist who developed those metrics weighs in.

3 months ago 0 0 0 0